Lyra Therapeutics Statistics
Total Valuation
LYRA has a market cap or net worth of $23.46 million. The enterprise value is -$27.79 million.
| Market Cap | 23.46M |
| Enterprise Value | -27.79M |
Important Dates
The last earnings date was Tuesday, April 30, 2024, after market close.
| Earnings Date | Apr 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
LYRA has 60.96 million shares outstanding. The number of shares has increased by 73.79% in one year.
| Shares Outstanding | 60.96M |
| Shares Change (YoY) | +73.79% |
| Shares Change (QoQ) | +28.53% |
| Owned by Insiders (%) | 0.70% |
| Owned by Institutions (%) | 88.03% |
| Float | 37.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.96 |
| Forward PS | 13.87 |
| PB Ratio | 0.30 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.78, with a Debt / Equity ratio of 0.49.
| Current Ratio | 4.78 |
| Quick Ratio | n/a |
| Debt / Equity | 0.49 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -78.80% and return on invested capital (ROIC) is -63.56%.
| Return on Equity (ROE) | -78.80% |
| Return on Assets (ROA) | -51.90% |
| Return on Capital (ROIC) | -63.56% |
| Revenue Per Employee | $15,413 |
| Profits Per Employee | -$631,899 |
| Employee Count | 109 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, LYRA has paid $59,000 in taxes.
| Income Tax | 59,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -86.02% in the last 52 weeks. The beta is 0.31, so LYRA's price volatility has been lower than the market average.
| Beta (1Y) | 0.31 |
| 52-Week Price Change | -86.02% |
| 50-Day Moving Average | 4.49 |
| 200-Day Moving Average | 4.20 |
| Relative Strength Index (RSI) | 13.33 |
| Average Volume (30 Days) | 2,860,114 |
Short Selling Information
The latest short interest is 413,791, so 0.68% of the outstanding shares have been sold short.
| Short Interest | 413,791 |
| Short Previous Month | 333,557 |
| Short % of Shares Out | 0.68% |
| Short % of Float | 1.10% |
| Short Ratio (days to cover) | 1.36 |
Income Statement
In the last 12 months, LYRA had revenue of $1.68 million and -$68.88 million in losses. Loss per share was -$1.20.
| Revenue | 1.68M |
| Gross Profit | 1.68M |
| Operating Income | -73.33M |
| Pretax Income | -68.82M |
| Net Income | -68.88M |
| EBITDA | -68.69M |
| EBIT | -68.82M |
| Loss Per Share | -$1.20 |
Balance Sheet
The company has $89.11 million in cash and $37.86 million in debt, giving a net cash position of $51.25 million or $0.84 per share.
| Cash & Cash Equivalents | 89.11M |
| Total Debt | 37.86M |
| Net Cash | 51.25M |
| Net Cash Per Share | $0.84 |
| Equity / Book Value | 77.50M |
| Book Value Per Share | 1.27 |
| Working Capital | 70.72M |
Cash Flow
In the last 12 months, operating cash flow was -$69.91 million and capital expenditures -$3.15 million, giving a free cash flow of -$73.06 million.
| Operating Cash Flow | -69.91M |
| Capital Expenditures | -3.15M |
| Free Cash Flow | -73.06M |
| FCF Per Share | -$1.14 |
Margins
Gross margin is 100.00%, with operating and profit margins of -4,364.94% and -4,099.82%.
| Gross Margin | 100.00% |
| Operating Margin | -4,364.94% |
| Pretax Margin | -4,096.31% |
| Profit Margin | -4,099.82% |
| EBITDA Margin | -4,088.57% |
| EBIT Margin | -4,096.31% |
| FCF Margin | -4,348.81% |
Dividends & Yields
LYRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -73.79% |
| Shareholder Yield | -73.79% |
| Earnings Yield | -293.60% |
| FCF Yield | -311.43% |
Analyst Forecast
The average price target for LYRA is $4.50, which is 1,074.94% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.50 |
| Price Target Difference | 1,074.94% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 151.48% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LYRA has an Altman Z-Score of -4.08 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.08 |
| Piotroski F-Score | 1 |